Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ABRAHAMSON I. A., Jr, HURWITZ P. Oxyphenonium (antrenyl), a substitute for atropine: a clinical study. AMA Arch Ophthalmol. 1954 Oct;52(4):519–523. doi: 10.1001/archopht.1954.00920050521003. [DOI] [PubMed] [Google Scholar]
- HAVENER W. H., FALLS H. F. Oxyphenonium (antrenyl); a potent atropine substitute. AMA Arch Ophthalmol. 1954 Oct;52(4):515–518. doi: 10.1001/archopht.1954.00920050517002. [DOI] [PubMed] [Google Scholar]
- Mann I. A NEW SYNTHETIC MYDRIATIC. Br J Ophthalmol. 1946 Jan;30(1):8–11. [PubMed] [Google Scholar]
- PLUMMER A. J., BARRETT W. E., RUTLEDGE R., YONKMAN F. F. Pharmacologic properties of antrenyl (oxyphenonium) (BA5473) diethyl(2-hydroxyethyl)methylammonium bromide alpha-phenyl-cyclohexaneglycolate, an anticholinergic agent. J Pharmacol Exp Ther. 1953 Jul;108(3):292–304. [PubMed] [Google Scholar]
- Riddell W. J. A CLINICAL TRIAL OF A SYNTHETIC MYDRIATIC (Dimethylaminoethyl Benzilate Ethochloride). Br J Ophthalmol. 1946 Jan;30(1):1–7. [PMC free article] [PubMed] [Google Scholar]
